Key result
The direct-to-angiosuite pathway shortened door-to-puncture time by 19.49 min but did not improve 90-day functional independence.
Why the study?
The direct-to-angiosuite pathway bypasses conventional cross-sectional neuroimaging triage to reduce door-to-puncture time during endovascular thrombectomy for large-vessel occlusion stroke, but whether this procedural gain translates into improved clinical outcomes remained uncertain after conflicting results from three randomized controlled trials.
Does the direct-to-angiosuite pathway improve 90-day functional independence (mRS 0-2) compared to standard-workflow endovascular thrombectomy in patients with large-vessel occlusion stroke?
Meta-Analysis (n=262)
Yes
Does the direct-to-angiosuite pathway improve 90-day functional independence (mRS 0-2) compared to standard-workflow endovascular thrombectomy in patients with large-vessel occlusion stroke?
Answers are grounded in this paper and cite their sources.
Although the direct-to-angiosuite pathway reduces door-to-puncture time by nearly 20 minutes in large-vessel occlusion stroke, pooled randomized evidence shows this does not translate into improved 90-day functional independence or survival and is associated with a higher rate of any intracranial hemorrhage.
Background: Endovascular thrombectomy (EVT) for large-vessel occlusion (LVO) stroke is profoundly time-sensitive. The direct-to-angiosuite (DTAS) pathway bypasses conventional cross-sectional neuroimaging triage to reduce door-to-puncture time, but whether this procedural gain translates into improved clinical outcomes remains uncertain after conflicting results from three randomized controlled trials (RCTs). We conducted a systematic review and meta-analysis to pool available randomized evidence. Methods: PubMed was searched for RCTs comparing DTAS to standard-workflow EVT, and three completed trials were included. Random-effects meta-analysis (restricted maximum likelihood, REML) was performed using Mantel-Haenszel risk ratios (RR) for binary outcomes and inverse-variance mean differences (MD) for continuous outcomes. The Primary outcome was 90-day functional independence (modified Rankin Scale [mRS] 0-2) and door-to-puncture (DTP) time was a key secondary outcome. Other Secondary outcomes included mRS 0-1, mRS 0-3, successful reperfusion (TICI ≥2b), 90-day mortality, symptomatic intracranial hemorrhage (sICH), and any intracranial hemorrhage (ICH). Heterogeneity was quantified by I² and Cochran’s Q. Results: Three RCTs were included (Pfaff 2020, Requena/ANGIOCAT 2021, Gory B./DIRECT ANGIO 2026; DTAS n = 132, control n = 130). DTAS significantly reduced DTP time (MD −19.49 min, 95% CI −32.95 to −6.03; p = 0.005), consistent in direction across all three trials. No functional outcome reached significance: mRS 0-2 pooled RR 1.17 (95% CI 0.65-2.11; p = 0.606; I² = 69.4%); mRS 0-1 RR 1.79 (95% CI 0.93-3.47; p = 0.084; single study); mRS 0-3 RR 1.02 (95% CI 0.65-1.62; p = 0.917). Ninety-day mortality was unchanged (RR 0.94, 95% CI 0.41-2.15; p = 0.874). Any-ICH risk was significantly elevated (RR 1.92, 95% CI 1.18-3.11; p = 0.009; I² = 0%), but the pooled sICH estimate was not statistically significant (RR 1.18, 95% CI 0.24-5.68; p = 0.84). Between-study heterogeneity was extreme for DTP time (I² = 93.0%), considerable for sICH (I² = 73.3%) and mRS 0-3 (I² = 72.9%), substantial for mRS 0-2 (I² = 69.4%) and 90-day mortality (I² = 59.9%), and low for any-ICH and reperfusion (I² = 0%). Conclusions: The DTAS pathway reproducibly reduces DTP time by approximately 19.5 minutes but in our analysis this time reduction was not shown to translate into improved 90-day functional outcomes or survival. Substantial between-study heterogeneity (I² = 69.4% for mRS 0-2) and the methodological limitations of DIRECT ANGIO, including a non-validated entry criterion and premature termination at 36% of planned enrollment, may explain our results. There was a statistically significant any-ICH signal (RR 1.92; p = 0.009), but no evidence of statistically significant differences in sICH. The field remains in genuine equipoise, and completion of WE-TRUST, DIRECT and ARTS-DTAS is required before definitive conclusions can be drawn.
No takes yet. Share an insight, caveat, or question.
Muharremi et al. (2026) conducted a meta-analysis in Large-vessel occlusion (LVO) stroke undergoing endovascular thrombectomy (n=262). Direct-to-angiosuite (DTAS) pathway for endovascular thrombectomy vs. Standard-workflow endovascular thrombectomy with conventional cross-sectional neuroimaging triage was evaluated on 90-day functional independence (modified Rankin Scale [mRS] 0-2) (RR 1.17, 95% CI 0.65-2.11, p=0.606). The direct-to-angiosuite pathway shortened door-to-puncture time by 19.49 min but did not improve 90-day functional independence.
Synapse has enriched 10 related papers. Consider them for comparative context: